It's about time to write off high-growth tech stocks, Goldman warned, saying software carries the highest multiples since the tech bubble.Marketsread more
Iran will surpass the internationally agreed levels of its low-enriched uranium levels in 10 days, the country's atomic energy body said Monday.Politicsread more
Boeing said the airline industry will need 44,040 new commercial airplanes by 2038. The market value of those planes would reach $6.8 trillion, up from $6.49 trillion...Airlinesread more
Apple is reportedly building three new iPhones for 2020, including two with 5G. It may also slightly change the screen sizes of the new iPhones.Technologyread more
Sotheby's announces it has signed an agreement to be acquired by BidFair USA, a venture owned by art collector Patrick Drahi.Marketsread more
Overall, extortion by email is growing significantly, according to the FBI's Internet Crime Compliant Center (IC3). Last year, these complaints rose 242% to 51,146 reported...Technologyread more
In a 7-2 ruling, over dissents from Justices Ruth Bader Ginsburg and Neil Gorsuch, the justices affirmed the so-called "dual sovereignty" exception to the Constitution's...Politicsread more
Target's nationwide cash register meltdown over the weekend created more than $16 million in buzz on the internet from news reports and other social media mentions, according...Retailread more
The chipmaker crush could persist and investors should be selective, but Nvidia looks like a clear buy, one market watcher says.Trading Nationread more
The top court scrapped a ruling from the Oregon Court of Appeals in favor of the same-sex couple. The owners of the bakery, which refused the make the cake due to religious...Politicsread more
Boeing reached a deal with British Airways to provide parts for some of its plane's made by rival manufacturer Airbus, part of Boeing's push to grow its services business.Airlinesread more
Verily, Alphabet's life science division, is building a tech-focused rehab campus in Dayton, Ohio to combat the opioid crisis.
Verily will join two health networks, Kettering Health Network and Premier Health, to create a nonprofit named OneFifteen. Alexandria Real Estate Equities will design and develop the campus, which will offer both inpatient and outpatient services.
There is no single solution to treating substance abuse, with strategies spanning from intensive rehabilitation programs to drop-in meetings. Verily hopes to get a better understanding of what works and what doesn't work in helping people get and stay sober.
"We're really on this quest to fundamentally transform behavioral health," Danielle Schlosser, senior clinical scientist of behavioral health at Verily, said in an interview. "I think anybody working in this field should be excited because we're going to see change with the level of investment going into this initiative."
Initially, Verily will focus on understanding what works in the clinic and then track patient behavior when they get out to see what sticks, Schlosser said. Verily will use a "variety of means" to track what works, she said, adding that patients would have to consent to being monitored.
"You could imagine something as simple as people answering a survey or more sophisticated technology to gain insight of who that person is, what they're encountering in their environment," she said.
Clinical care will be provided by an operating partner of OneFifteen, Samaritan Behavioral Health, Inc., a subsidiary of Premier Health. Verily will integrate its technology into the facility to analyze and measure how effective interventions are.
OneFifteen will begin seeing individuals for inpatient and outpatient care in the spring of 2019. The full campus is expected to be completed in 2020.
Over time, One Fifteen wants to change how addiction is treated and how providers are paid, OneFifteen CEO Marti Taylor said in an interview. Verily and its partners will fund OneFifteen.
"Because we will have facilities, an entire ecosystem and data, we'll be able to take a more holistic understanding of a person's health both inside and outside as we follow them long-term," Taylor said. "It's pretty unique being able to understand their care and advance evidence-based treatment."